Gene Variant Databases
Advances in Genomic Testing for Rare Disease Diagnostics
82 views
Over the past decade, whole-exome and whole-genome sequencing have transformed the diagnosis of patients with suspected rare genetic diseases. However, despite recent advancements, a large number of patients with rare genetic diseases remains undiagnosed for years because they have limited access to comprehensive genomic testing.
In this virtual roundtable of leading rare disease experts, panelists will discuss:
The state of clinical genomic testing at their institutions.
How recent advances in sequencing technology and data analysis, including artificial intelligence (AI), are increasing diagnostic rate.
How barriers to patient access to testing can be removed to improve the care of all people living with rare genetic diseases.
Related videos
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate...
The cancer drug discovery landscape is shifting. While research continues to...
Gene Variant Databases
Using COSMIC to predict, identify, and avoid mutational consequences of cancer therapies during...
Whether your lab is researching and developing targeted cancer therapies or...
Gene Variant Databases
Case studies: Real world examples of how labs can use HGMD Professional to mitigate errors in...
The clinical interpretation of genetic testing results remains one of the...
Gene Variant Databases
Insights into cancer genomics via COSMIC v98
Our understanding of cancer mechanisms, genetics and complexities continues...